FEATURES
Here are just a few editorial highlights from the DDNews Cancer Research News site and other online vehicles of DDNews magazine to get you acquainted with the website and show you the range of our coverage.
 

 
By Dr. Dragan Cicic, Actinium Pharmaceuticals Inc.
Patients with blood cancers often face poor long-term survival outcomes, but a new treatment approach could offer more effective targeting of cancer cells as well as lower toxicity.
 
By Kelsey Kaustinen, DDNews Senior Editor
If all milestones are met, the agreement could be worth up to $817 million
 
By Kelsey Kaustinen, DDNews Senior Editor
The effectiveness of anthracyclines, a standard of cancer care, is marred by the associated heart damage they cause; a recent study, however, reports that wrapping the drugs in a fatty cover can minimize cardiotoxicity.
 
By Lloyd Dunlap, DDNews Managing Editor
Immunomedics Inc. has received notice from the U.S. Food and Drug Administration designating as a Fast Track development program the investigation of sacituzumab govitecan, the company's lead antibody-drug conjugate, for the treatment of patients with triple-negative breast cancer
 
By Kelsey Kaustinen, DDNews Senior Editor
When the STP axis is expressed, causing low REST protein levels, clinical outcomes in the lab are poor, while inhibition of the axis was found to increase REST levels, which impaired tumor formation and progression.
 
 
 

 
Click on the following to view the "Top 5" lists of cancer-related stories that we send out periodically via email:
 
2014
 
The January Top 5 was sponsored by the American Association for Cancer Research.
 
The February Top 5 was sponsored by Trevigen.
 
The March Top 5 was sponsored by Trevigen.
 
The April Top 5 was sponsored by Bio-Rad Laboratories.
 
The August Top 5 was sponsored by Gilson.
 
The September Top 5 was sponsored by Cell Signaling Technology
 
The October Top 5 was sponsored by Agilent Technologies
 
The November Top 5 was sponsored by Charles River Laboratories
 
 

ARCHIVES
The September Top 5 was sponsored by Bio-Rad Laboratories.

April 2013
The April Top 5 was sponsored by PerkinElmer.

March 2013
The March Top 5 was sponsored by Olympus.
 
The October Top 5 was sponsored by Bio-Rad Laboratories.
 
The September Top 5 was sponsored by Waters Corporation.
 
The April Top 5 was sponsored by Bio-Rad Laboratories.
 
The March Top 5 was sponsored by Bio-Rad Laboratories.
 
The February Top 5 was sponsored by Bio-Rad Laboratories.
 
The November Top 5 was sponsored by Rockland.
 
The October Top 5 was sponsored by Rockland.
 
The September Top 5 was sponsored by Rockland.
 
The April Top 5 was sponsored by Seahorse Bioscience and Trevigen, Inc.
 
The March Top 5 was sponsored by Seahorse Bioscience and Trevigen, Inc.
 
The February Top 5 was sponsored by Seahorse Bioscience and Trevigen, Inc.
 
 
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2015 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.